Peter J Crick, William J Griffiths, Juan Zhang, Martin Beibel, Jonas Abdel-Khalik, Jens Kuhle, Andreas W Sailer, Yuqin Wang
Multiple sclerosis (MS) is an autoimmune, inflammatory disease of the central nervous system (CNS). We have measured the levels of over 20 non-esterified sterols in plasma and cerebrospinal fluid (CSF) from patients suffering from MS, inflammatory CNS disease, neurodegenerative disease and control patients. Analysis was performed following enzyme-assisted derivatisation by liquid chromatography-mass spectrometry (LC-MS) exploiting multistage fragmentation (MS ). We found increased concentrations of bile acid precursors in CSF from each of the disease states and that patients with inflammatory CNS disease classified as suspected autoimmune disease or of unknown aetiology also showed elevated concentrations of 25-hydroxycholestertol (25-HC, P < 0.05) in CSF. Cholesterol concentrations in CSF were not changed except for patients diagnosed with amyotrophic lateral sclerosis (P < 0.01) or pathogen-based infections of the CNS (P < 0.05) where they were elevated. In plasma, we found that 25-HC (P < 0.01), (25R)26-hydroxycholesterol ((25R)26-HC, P < 0.05) and 7α-hydroxy-3-oxocholest-4-enoic acid (7αH,3O-CA, P < 0.05) were reduced in relapsing-remitting MS (RRMS) patients compared to controls. The pattern of reduced plasma levels of 25-HC, (25R)26-HC and 7αH,3O-CA was unique to RRMS. In summary, in plasma, we find that the concentration of 25-HC in RRMS patients is significantly lower than in controls. This is consistent with the hypothesis that a lower propensity of macrophages to synthesise 25-HC will result in reduced negative feedback by 25-HC on IL-1 family cytokine production and exacerbated MS. In CSF, we find that the dominating metabolites reflect the acidic pathway of bile acid biosynthesis and the elevated levels of these in CNS disease is likely to reflect cholesterol release as a result of demyelination or neuronal death. 25-HC is elevated in patients with inflammatory CNS disease probably as a consequence of up-regulation of the type 1 interferon-stimulated gene cholesterol 25-hydroxylase in macrophages.
Neurology. 2010 Jan 5;74 Suppl 1:S2-8
[PMID:
20038759]
J Lipid Res. 2014 Feb;55(2):313-8
[PMID:
24319290]
Immunity. 2013 Jan 24;38(1):106-18
[PMID:
23273843]
J Biol Chem. 2010 Feb 12;285(7):4666-79
[PMID:
19996111]
J Alzheimers Dis. 2011;24(4):669-79
[PMID:
21297254]
J Autoimmun. 2015 Jan;56:45-55
[PMID:
25456971]
Neurosci Lett. 2006 Apr 10-17;397(1-2):83-7
[PMID:
16406316]
Neurosci Lett. 2013 Oct 25;555:102-5
[PMID:
24035896]
Nat Rev Neurol. 2014 Apr;10(4):225-38
[PMID:
24638138]
Antioxid Redox Signal. 2009 Mar;11(3):407-20
[PMID:
18785817]
J Leukoc Biol. 2010 Dec;88(6):1071-2
[PMID:
21123296]
J Lipid Res. 2007 Apr;48(4):944-51
[PMID:
17251592]
Mol Aspects Med. 2009 Jun;30(3):171-9
[PMID:
19248803]
Nature. 2011 Jul 27;475(7357):519-23
[PMID:
21796211]
Neurosci Lett. 2009 Oct 2;462(1):89-93
[PMID:
19560513]
Science. 1999 May 21;284(5418):1365-8
[PMID:
10334993]
J Biol Chem. 2004 Aug 13;279(33):34674-81
[PMID:
15148325]
Lancet Neurol. 2010 Jul;9(7):727-39
[PMID:
20610348]
Immunology. 2013 May;139(1):11-8
[PMID:
23360426]
Nature. 2011 Jul 27;475(7357):524-7
[PMID:
21796212]
Annu Rev Biochem. 2003;72:137-74
[PMID:
12543708]
Biochim Biophys Acta. 2010 Aug;1801(8):917-23
[PMID:
20211758]
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12163-8
[PMID:
25092323]
Science. 2014 Aug 8;345(6197):679-84
[PMID:
25104388]
Nature. 1996 Oct 24;383(6602):728-31
[PMID:
8878485]
Nat Rev Immunol. 2014 Nov;14(11):731-43
[PMID:
25324126]
Nat Genet. 2013 Nov;45(11):1353-60
[PMID:
24076602]
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16764-9
[PMID:
19805370]
Biochimie. 2013 Mar;95(3):448-54
[PMID:
23111110]
J Lipid Res. 2009 Nov;50(11):2258-64
[PMID:
19502589]
Nat Rev Drug Discov. 2014 Jun;13(6):433-44
[PMID:
24833295]
Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):223-8
[PMID:
12509506]
J Clin Invest. 2014 Nov;124(11):4829-42
[PMID:
25271621]
Mol Cell Biol. 2004 Sep;24(18):8154-66
[PMID:
15340076]
Biochem J. 1997 Feb 15;322 ( Pt 1):175-84
[PMID:
9078259]
Clin Chem. 2015 Feb;61(2):400-11
[PMID:
25512642]
J Leukoc Biol. 2010 Dec;88(6):1081-7
[PMID:
20699362]
Immunity. 2013 Jan 24;38(1):92-105
[PMID:
23273844]
Neuron. 2016 Jun 1;90(5):948-54
[PMID:
27253448]
J Clin Invest. 2006 Mar;116(3):607-14
[PMID:
16511593]
Nat Immunol. 2013 Sep;14(9):893-900
[PMID:
23959186]
Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):7587-92
[PMID:
26023184]
J Biol Chem. 1997 Feb 7;272(6):3137-40
[PMID:
9013544]
Brain Pathol. 2007 Apr;17(2):210-8
[PMID:
17388952]
